Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers

V. Moschese, A. Martino, C. Fundaro, A. Plebani, G. Cappelli, V. Lombardi, M. Alimandi, S. Scaccia, E. Galli, P. Rossi, P. Orlandi

Research output: Contribution to journalArticle

Abstract

Pre- and postvaccination antitetanus (AT) antibody values were investigated in children born to human immunodeficiency virus type 1 (HIV- 1)-infected mothers. Twenty-four uninfected and 14 infected children were enrolled in the study as judged by the Centers for Disease Control and Prevention (CDC) classification system and viral isolation or PCR assays. AT antibody values were determined in sera by hemagglutination assay. CD4 lymphocyte counts, serum immunoglobulins, and p24 antigenemia were also evaluated. Prior to vaccination concentrations of immunoglobulins were higher and CD4 positive lymphocyte counts were lower in the infected infants than in the noninfected infants. Following primary vaccination, an appropriate antibody response was found in 22 (92%) of 24 uninfected children and in 4 (29%) of 14 infected ones. Mean AT antibody levels were lower in infected than in uninfected infants, with values differing more significantly after the second tetanus toxoid (TT) administration (p values: 0.06, 0.01, and 0.03 after the first, second, and third doses, respectively). Also, uninfected children showed a more than 4-fold rise in specific antibody concentration after the second TT immunization, which was not found in infected infants (1.1-4.28 HU/ml vs 0.27-0.31 HU/ml in uninfected and infected children, respectively). Among the infected children no difference in the AT antibody levels of those with acquired immunodeficiency syndrome (AIDS) and those with non-AIDS status could be detected. In conclusion, our data confirm that symptomatic HIV-1-infected infants have a reduced capacity to sustain an antibody response to recall antigens.

Original languageEnglish
Pages (from-to)79-85
Number of pages7
JournalPediatric AIDS and HIV Infection
Volume5
Issue number2
Publication statusPublished - 1994

Fingerprint

Tetanus Toxoid
Immunization
Mothers
HIV
Antibodies
CD4 Lymphocyte Count
Antibody Formation
HIV-1
Immunoglobulins
Vaccination
CD4-Positive T-Lymphocytes
Hemagglutination
Centers for Disease Control and Prevention (U.S.)
Serum
Acquired Immunodeficiency Syndrome
Antigens
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Moschese, V., Martino, A., Fundaro, C., Plebani, A., Cappelli, G., Lombardi, V., ... Orlandi, P. (1994). Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers. Pediatric AIDS and HIV Infection, 5(2), 79-85.

Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers. / Moschese, V.; Martino, A.; Fundaro, C.; Plebani, A.; Cappelli, G.; Lombardi, V.; Alimandi, M.; Scaccia, S.; Galli, E.; Rossi, P.; Orlandi, P.

In: Pediatric AIDS and HIV Infection, Vol. 5, No. 2, 1994, p. 79-85.

Research output: Contribution to journalArticle

Moschese, V, Martino, A, Fundaro, C, Plebani, A, Cappelli, G, Lombardi, V, Alimandi, M, Scaccia, S, Galli, E, Rossi, P & Orlandi, P 1994, 'Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers', Pediatric AIDS and HIV Infection, vol. 5, no. 2, pp. 79-85.
Moschese V, Martino A, Fundaro C, Plebani A, Cappelli G, Lombardi V et al. Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers. Pediatric AIDS and HIV Infection. 1994;5(2):79-85.
Moschese, V. ; Martino, A. ; Fundaro, C. ; Plebani, A. ; Cappelli, G. ; Lombardi, V. ; Alimandi, M. ; Scaccia, S. ; Galli, E. ; Rossi, P. ; Orlandi, P. / Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers. In: Pediatric AIDS and HIV Infection. 1994 ; Vol. 5, No. 2. pp. 79-85.
@article{5c65e47a419d4154b17c578564306e00,
title = "Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers",
abstract = "Pre- and postvaccination antitetanus (AT) antibody values were investigated in children born to human immunodeficiency virus type 1 (HIV- 1)-infected mothers. Twenty-four uninfected and 14 infected children were enrolled in the study as judged by the Centers for Disease Control and Prevention (CDC) classification system and viral isolation or PCR assays. AT antibody values were determined in sera by hemagglutination assay. CD4 lymphocyte counts, serum immunoglobulins, and p24 antigenemia were also evaluated. Prior to vaccination concentrations of immunoglobulins were higher and CD4 positive lymphocyte counts were lower in the infected infants than in the noninfected infants. Following primary vaccination, an appropriate antibody response was found in 22 (92{\%}) of 24 uninfected children and in 4 (29{\%}) of 14 infected ones. Mean AT antibody levels were lower in infected than in uninfected infants, with values differing more significantly after the second tetanus toxoid (TT) administration (p values: 0.06, 0.01, and 0.03 after the first, second, and third doses, respectively). Also, uninfected children showed a more than 4-fold rise in specific antibody concentration after the second TT immunization, which was not found in infected infants (1.1-4.28 HU/ml vs 0.27-0.31 HU/ml in uninfected and infected children, respectively). Among the infected children no difference in the AT antibody levels of those with acquired immunodeficiency syndrome (AIDS) and those with non-AIDS status could be detected. In conclusion, our data confirm that symptomatic HIV-1-infected infants have a reduced capacity to sustain an antibody response to recall antigens.",
author = "V. Moschese and A. Martino and C. Fundaro and A. Plebani and G. Cappelli and V. Lombardi and M. Alimandi and S. Scaccia and E. Galli and P. Rossi and P. Orlandi",
year = "1994",
language = "English",
volume = "5",
pages = "79--85",
journal = "Pediatric AIDS and HIV Infection",
issn = "1045-5418",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Response to tetanus toxoid primary immunization in children born to HIV seropositive mothers

AU - Moschese, V.

AU - Martino, A.

AU - Fundaro, C.

AU - Plebani, A.

AU - Cappelli, G.

AU - Lombardi, V.

AU - Alimandi, M.

AU - Scaccia, S.

AU - Galli, E.

AU - Rossi, P.

AU - Orlandi, P.

PY - 1994

Y1 - 1994

N2 - Pre- and postvaccination antitetanus (AT) antibody values were investigated in children born to human immunodeficiency virus type 1 (HIV- 1)-infected mothers. Twenty-four uninfected and 14 infected children were enrolled in the study as judged by the Centers for Disease Control and Prevention (CDC) classification system and viral isolation or PCR assays. AT antibody values were determined in sera by hemagglutination assay. CD4 lymphocyte counts, serum immunoglobulins, and p24 antigenemia were also evaluated. Prior to vaccination concentrations of immunoglobulins were higher and CD4 positive lymphocyte counts were lower in the infected infants than in the noninfected infants. Following primary vaccination, an appropriate antibody response was found in 22 (92%) of 24 uninfected children and in 4 (29%) of 14 infected ones. Mean AT antibody levels were lower in infected than in uninfected infants, with values differing more significantly after the second tetanus toxoid (TT) administration (p values: 0.06, 0.01, and 0.03 after the first, second, and third doses, respectively). Also, uninfected children showed a more than 4-fold rise in specific antibody concentration after the second TT immunization, which was not found in infected infants (1.1-4.28 HU/ml vs 0.27-0.31 HU/ml in uninfected and infected children, respectively). Among the infected children no difference in the AT antibody levels of those with acquired immunodeficiency syndrome (AIDS) and those with non-AIDS status could be detected. In conclusion, our data confirm that symptomatic HIV-1-infected infants have a reduced capacity to sustain an antibody response to recall antigens.

AB - Pre- and postvaccination antitetanus (AT) antibody values were investigated in children born to human immunodeficiency virus type 1 (HIV- 1)-infected mothers. Twenty-four uninfected and 14 infected children were enrolled in the study as judged by the Centers for Disease Control and Prevention (CDC) classification system and viral isolation or PCR assays. AT antibody values were determined in sera by hemagglutination assay. CD4 lymphocyte counts, serum immunoglobulins, and p24 antigenemia were also evaluated. Prior to vaccination concentrations of immunoglobulins were higher and CD4 positive lymphocyte counts were lower in the infected infants than in the noninfected infants. Following primary vaccination, an appropriate antibody response was found in 22 (92%) of 24 uninfected children and in 4 (29%) of 14 infected ones. Mean AT antibody levels were lower in infected than in uninfected infants, with values differing more significantly after the second tetanus toxoid (TT) administration (p values: 0.06, 0.01, and 0.03 after the first, second, and third doses, respectively). Also, uninfected children showed a more than 4-fold rise in specific antibody concentration after the second TT immunization, which was not found in infected infants (1.1-4.28 HU/ml vs 0.27-0.31 HU/ml in uninfected and infected children, respectively). Among the infected children no difference in the AT antibody levels of those with acquired immunodeficiency syndrome (AIDS) and those with non-AIDS status could be detected. In conclusion, our data confirm that symptomatic HIV-1-infected infants have a reduced capacity to sustain an antibody response to recall antigens.

UR - http://www.scopus.com/inward/record.url?scp=0028223009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028223009&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028223009

VL - 5

SP - 79

EP - 85

JO - Pediatric AIDS and HIV Infection

JF - Pediatric AIDS and HIV Infection

SN - 1045-5418

IS - 2

ER -